Search for: "Lisa Ouellette" Results 101 - 120 of 173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2017, 11:56 pm by Lawrence B. Ebert
Further to the IPBiz post The theme of independent invention, and whether the same thing was invented , which in part discussed Mark Lemley'sMyth of the Sole Inventor, a previous post on IPBiz had noted:Separately, some commentary from Lisa Larrimore Ouellette related to Lemley's Myth of the Sole Inventor, and "review" of law review articles:Lemley isn't making any claims about the scope of the patents these inventors received, so whether… [read post]
7 Aug 2015, 1:39 pm by Rebecca Tushnet
   Lisa Larrimore Ouellette, Stanford Law School Collegiality/welcoming is a big benefit of coming here. [read post]
5 Mar 2020, 5:15 am by Léon Dijkman
Daniel Hemel and Lisa Larrimore Ouellette suggested that the government award a "large cash prize for any firm that develops a successful coronavirus vaccine". [read post]
3 Feb 2016, 11:40 am by Lawrence B. Ebert
And in the few circumstances where that is not true – where inventions truly are "singletons" – it is often because of an accident or error in the experiment rather than a conscious effort to invent.In spite of Lemley's explicit reference to "bamboo" in the abstract of his law review, Lisa Larrimore Ouellette wrote:Lemley isn't making any claims about the scope of the patents these inventors received, so whether "bamboo" appears… [read post]
20 Jan 2015, 12:12 pm by Michael Risch
Luckily, Lisa Larrimore Ouellette, who runs Written Description, heard about my bloglessness and invited me to join her blog. [read post]
24 Jun 2016, 9:05 am by Amy Howe
At Legal Aggregate, Lisa Ouellette analyzes the Court’s recent decision in Cuozzo Speed Technologies v. [read post]
6 Oct 2014, 5:36 am by Amy Howe
  At Written Description, Lisa Larrimore Ouellette previews next week’s argument in Teva Pharmaceuticals v. [read post]
1 Jun 2017, 4:23 am by Edith Roberts
” At Stanford Law School’s Legal Aggregate blog, Lisa Larrimore Ouellette looks at the court’s decision inTC Heartland LLC v. [read post]
16 Jun 2020, 6:57 am by Lisa Larrimore Ouellette
Guest post by Jake Linford, Loula Fuller and Dan Myers Professor, Florida State University College of Law, whose trademark law scholarship I have highlighted on JotwellI want to thank Lisa Ouellette for inviting me to blog about United States Patent & Trademark Office v. [read post]
14 Jan 2019, 2:40 am by Camilla Alexandra Hrdy
(Incidentally, one of the most concise summaries I've ever read of the inconclusive empirical evidence regarding the costs and benefits of patents appears on pages 75-87 of Lisa Larrimore Ouellete's article, Patent Experimentalism.)To some degree, Biagioli's article has a lot in common with these prior articles, expressing skepticism about whether patents and IP, generally, bring benefits that are greater than the costs, and about how society justifies the institution in… [read post]
11 Jun 2020, 2:30 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceOver the past two weeks, the United States—already hit hard by the COVID-19 pandemic—has reckoned with another public health crisis: police violence against Black Americans. [read post]
7 Apr 2020, 7:34 am by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowThe escalating pandemic has caused devastating shortages not only of ventilators and personal protective equipment like masks, but also of essential medicines needed to treat COVID-19 patients. [read post]
27 Apr 2020, 1:27 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowHealth systems worldwide are facing shortages of crucial medical supplies, including personal protective equipment (PPE), diagnostic testing components including kits and nasal swabs, and even ventilators or ventilator parts. [read post]
18 Dec 2020, 6:37 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsThe past two weeks have been full of exciting COVID-19 vaccine news, including the FDA’s emergency use authorizations (EUAs) for the Pfizer–BioNTech and Moderna vaccines and the nationwide rollout of Pfizer’s vaccine. [read post]
27 May 2020, 12:00 pm by Lisa Larrimore Ouellette
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
3 May 2021, 8:36 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWe have written before about the challenges of making decisions under scientific uncertainty and the simultaneous importance and difficulty of developing high-quality clinical evidence under pandemic circumstances. [read post]
30 Nov 2020, 7:24 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceWhen President-elect Joe Biden is inaugurated in January, his administration will face the ongoing public health and economic challenges created by COVID-19. [read post]
3 Mar 2022, 6:43 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]